Market closedNon-fractional

TELA Bio/TELA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About TELA Bio

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

Ticker

TELA

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Malvern, United States

Employees

227

TELA Bio Metrics

BasicAdvanced
$108M
Market cap
-
P/E ratio
-$1.66
EPS
1.00
Beta
-
Dividend rate
$108M
1
4.125
3.103
293.896
293.896
-8.52%
-43.28%
-459.89%
1.68
7.4
8.62
-2.385
40.03%
-36.23%
45.82%
-8.47%

What the Analysts think about TELA Bio

Analyst Ratings

Majority rating from 5 analysts.
Buy

TELA Bio Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-33.73% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$17M
-1.78%
Net income
-$5.6M
-56.25%
Profit margin
-33.73%
-55.46%

TELA Bio Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 54.15%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.46
-$0.45
-$0.53
-$0.23
-
Expected
-$0.53
-$0.49
-$0.43
-$0.50
-$0.47
Surprise
-13.70%
-8.50%
21.90%
-54.15%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for TELA Bio stock?

TELA Bio (TELA) has a market cap of $108M as of July 06, 2024.

What is the P/E ratio for TELA Bio stock?

The price to earnings (P/E) ratio for TELA Bio (TELA) stock is 0 as of July 06, 2024.

Does TELA Bio stock pay dividends?

No, TELA Bio (TELA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next TELA Bio dividend payment date?

TELA Bio (TELA) stock does not pay dividends to its shareholders.

What is the beta indicator for TELA Bio?

TELA Bio (TELA) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell TELA Bio stock

Buy or sell TELA Bio stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing